Xometry (NASDAQ:XMTR) Price Target Raised to $55.00

Xometry (NASDAQ:XMTR) had its target price lifted by UBS Group from $54.00 to $55.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other research analysts have also recently issued reports on the company. Zacks Research cut Xometry from a “hold” rating to a “strong sell” rating in a report on Friday, January 30th. Citigroup cut their price target on Xometry from $75.00 to $65.00 and set a “buy” rating on the stock in a research note on Wednesday. Royal Bank Of Canada decreased their price objective on Xometry from $64.00 to $55.00 and set a “sector perform” rating for the company in a research note on Wednesday. The Goldman Sachs Group upped their price objective on Xometry from $49.00 to $56.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. Finally, William Blair restated an “outperform” rating on shares of Xometry in a report on Tuesday. Five analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $62.00.

Xometry Trading Down 9.4%

Shares of NASDAQ:XMTR opened at $41.01 on Wednesday. The stock’s 50-day moving average is $60.65 and its 200-day moving average is $56.02. The company has a market cap of $2.10 billion, a P/E ratio of -33.61 and a beta of 0.86. The company has a debt-to-equity ratio of 1.18, a quick ratio of 3.58 and a current ratio of 3.76. Xometry has a 52-week low of $18.59 and a 52-week high of $73.87.

Xometry (NASDAQ:XMTR) last released its earnings results on Tuesday, February 24th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.12 by $0.04. Xometry had a negative net margin of 8.99% and a negative return on equity of 5.49%. The firm had revenue of $192.40 million during the quarter, compared to analysts’ expectations of $183.37 million. During the same period in the prior year, the company earned $0.06 EPS. The business’s quarterly revenue was up 29.5% compared to the same quarter last year. Equities research analysts predict that Xometry will post -0.66 earnings per share for the current year.

Insider Transactions at Xometry

In related news, CFO James Miln sold 15,103 shares of the company’s stock in a transaction dated Thursday, February 26th. The shares were sold at an average price of $43.46, for a total value of $656,376.38. Following the transaction, the chief financial officer directly owned 173,123 shares in the company, valued at approximately $7,523,925.58. This represents a 8.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Randolph Altschuler sold 31,928 shares of the business’s stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $43.44, for a total value of $1,386,952.32. Following the completion of the sale, the chief executive officer owned 372,377 shares of the company’s stock, valued at approximately $16,176,056.88. This trade represents a 7.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 127,852 shares of company stock valued at $6,993,940. Corporate insiders own 9.66% of the company’s stock.

Hedge Funds Weigh In On Xometry

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Royal Bank of Canada boosted its position in shares of Xometry by 5.0% during the 1st quarter. Royal Bank of Canada now owns 60,669 shares of the company’s stock worth $1,511,000 after acquiring an additional 2,899 shares in the last quarter. AQR Capital Management LLC acquired a new position in shares of Xometry in the 1st quarter worth approximately $692,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Xometry by 7.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,054 shares of the company’s stock worth $649,000 after acquiring an additional 1,877 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Xometry by 26.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 452,682 shares of the company’s stock valued at $11,281,000 after acquiring an additional 95,154 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in Xometry in the 2nd quarter valued at about $1,704,000. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Xometry

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Company delivered a solid quarter — revenue grew ~29.5% year‑over‑year and Q4 EPS beat consensus, supporting the long‑term growth story. Read More.
• Positive Sentiment: Management will attend investor conferences (including a March 3 fireside chat), giving investors more access to management and clarity on the upcoming CEO transition. Read More.
• Positive Sentiment: Some firms remain constructive — Citigroup and Wedbush kept buy/outperform stances even while trimming targets, which preserves upside conviction among bullish investors. Read More.
• Neutral Sentiment: A number of analysts adjusted targets with mixed tones — UBS and Royal Bank of Canada moved to neutral/sector‑perform levels, trimming upside but not issuing outright sell calls. This reduces short‑term consensus upside but isn’t uniformly bearish. Read More.
• Neutral Sentiment: Institutional ownership is very high (~97%), so large insider transactions and analyst flows can disproportionately influence intraday liquidity and volatility. Read More.
• Negative Sentiment: Significant, contemporaneous insider selling — CEO, CFO, President, CTO and other insiders reported multi‑thousand‑share sales on Feb. 26. Heavy insider sales on the same day typically spook investors and add downward pressure. Read More.
• Negative Sentiment: Analyst downgrades and target cuts triggered selling flow — several outlets reported the stock drifting lower after the analyst actions, which appears to be a primary catalyst for today’s weakness. Read More.
• Negative Sentiment: Conflicting narratives around the earnings release (some headlines emphasizing the beat, others highlighting margin/negative net income issues) increase short‑term uncertainty and volatility. Read More.

About Xometry

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.